Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 or COVID-2019) is a novel emerging global health threatening pathogen, originating from Wuhan, China in December 2019 [@b0005]. Understanding immunopathogenesis of COVID-19 is very important, not only in the management of complications, but also developing efficient treatment regimens. Why elderly adults with COVID-19 have poor treatment response and greater mortality than younger individuals? [@b0010].

IL-6 is known to be potent mediator of inflammatory processes of elderly named Alzheimer disease. Improvement of dementia with cytotoxic treatment was reported in a case of Alzheimer disease. It has also been shown that decreased estrogen and testosterone level in elderly patient is unable to downregulate IL-6 gene expression [@b0015], [@b0020], [@b0025]. Also, estrogen result in decrease pro-inflammatory cytokine IFN, IL-2, IL-6 TNF a production, and increased anti- inflammatory cytokine IL-4 and IL-5 production [@b0030].

On the other hand, a variety of potantial anti-inflammatory agents are currently investigating in COVID-19. One of them is hydroxychloroquine via to inhibit immune response to the COVID-19 [@b0005], [@b0035]. It inhibits the production of TNF, IFNα, IL-6 and natural killer cell [@b0040], [@b0045], [@b0050]. Moreover, co-medication of selective estrogen receptor modulatory with hydroxychloroquine is associated with eye toxicity due to synergistic inhibition of lysosomal enzymes [@b0055].

Taken all together, it may be suggested that endogenous pro- inflamatory modulation agent (estrogen and testesteron) may be effective in management of elderly COVID-19 by decreasing pro-inflammatory cytokine. Also, doping administration of anabolizan steroids may slow progression of elderly COVID-19 with the effects mentioned above.
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